Country: আয়ার্লণ্ড
ভাষা: ইংরেজি
সূত্র: HPRA (Health Products Regulatory Authority)
Timolol; Latanoprost
Laboratoires Thea
S01ED; S01ED51
Timolol; Latanoprost
50micrograms/ml +5 milligram(s)/millilitre
Eye drops, solution in single-dose container
Product subject to prescription which may be renewed (B)
Beta blocking agents1); timolol, combinations
Marketed
2018-06-22
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT FIXAPOST 50 MICROGRAMS/ML + 5 MG/ML EYE DROPS, SOLUTION IN SINGLE-DOSE CONTAINER latanoprost / timolol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Fixapost is and what it is used for 2. What you need to know before you use Fixapost 3. How to use Fixapost 4. Possible side effects 5. How to store Fixapost 6. Contents of the pack and other information 1. WHAT FIXAPOST IS AND WHAT IT IS USED FOR Fixapost contains two medicines: latanoprost and timolol. Latanoprost belongs to a group of medicines known as prostaglandin analogues. Timolol belongs to a group of medicines known as beta-blockers. Latanoprost works by increasing the natural outflow of fluid from the eye into the bloodstream. Timolol works by slowing the formation of fluid in the eye. Fixapost is used to reduce the pressure in your eye if you have conditions known as open angle glaucoma or ocular hypertension. Both these conditions are linked to an increase in the pressure within your eye, eventually affecting your eyesight. Your doctor will usually prescribe you Fixapost when other medicines have not worked adequately. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE FIXAPOST Fixapost can be used in adult men and women (including the elderly), but is not recommended for use if you are less than 18 years of age. DO NOT USE FIXAPOST: - if you are allergic (hypersensitive) to latanoprost, timolol, beta-blockers, or any of the other ingredients of this medicine (listed in section 6), - if y সম্পূর্ণ নথি পড়ুন
Health Products Regulatory Authority 02 May 2023 CRN00DJYW Page 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Fixapost 50 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution contains latanoprost 50 micrograms and timolol maleate equivalent to 5 mg timolol. One drop contains approximately 1.5 micrograms of latanoprost and 0.15 mg of timolol. Excipient with known effect 1 ml eye drops solution contains 50 mg of macrogolglycerol hydroxystearate (castor oil polyoxyl hydrogenated). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Eye drops, solution in single-dose container. Slightly yellow and opalescent solution, practically free from particles. pH: 5.7 – 6.2 Osmolality: 300-340 mosmol/kg. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Fixapost is indicated in adults (including the elderly) for the reduction of intraocular pressure (IOP) in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta‑blockers or prostaglandin analogues. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults (including the elderly)_ Recommended therapy is one eye drop in the affected eye(s) once daily. If one dose is missed, treatment should continue with the next dose as planned. The dose should not exceed one drop in the affected eye(s) daily. _Paediatric population_ The safety and efficacy of Fixapost in children and adolescents has not been established. Method of administration Ocular use. As with any eye drops, to reduce possible systemic absorption, it is recommended that the lachrymal sac be compressed at the medial canthus (punctal occlusion) for two minutes. This should be performed immediately following the instillation of each drop. Contact lenses should be removed before instillation of the eye drops and may be reinserted after 15 minutes. If more than one topical ophthalmic medicine is being used, the medicinal products should be administe সম্পূর্ণ নথি পড়ুন